JOJuri Ota-Kuroki

Juri Ota-Kuroki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Juri Ota-Kuroki has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biofluid Proteomic Biomarker Discovery in a Large Animal Model of CLN2 Neuronal Ceroid Lipofuscinosis

    by Brandie R. Morgan-Jack, Grace R. Kick, Zhen Lyu, Trupti Joshi, Brian Mooney, Joan R. Coates, Juri Ota-Kuroki, Martin L. Katz, Rebecca E. H. Whiting

    CLN2 disease is a fatal lysosomal storage disorder caused by deficiency of the lysosomal enzyme tripeptidyl peptidase 1 (TPP1), resulting in progressive neurodegeneration and non-neuronal pathology. While enzyme replacement therapy has improved disease management, there remains a critical need for objective molecular biomarkers capable of monitoring disease progression and therapeutic response. The purpose of this study was to utilize a canine model of CLN2 disease to investigate proteomic changes in cerebrospinal fluid (CSF) and in minimally invasive biofluids tears and plasma to identify candidate disease biomarkers. Untargeted proteomic analysis was conducted using these biofluids from unaffected controls and CLN2-affected dogs at presymptomatic, symptomatic, and advanced disease stages. CSF demonstrated the greatest degree of proteomic alterations over the disease progression. Proteins associated with cytoskeletal organization, synaptic signaling, lysosomal biology, mitochondrial metabolism, lipid homeostasis, and inflammatory responses were significantly altered. Tear fluid demonstrated overlapping biological themes with CSF, particularly involving mitochondrial metabolism, lysosomal function, and lipid-associated pathways. In contrast, plasma proteomic alterations were comparatively modest but supported systemic changes associated with extracellular signaling, inflammation, and lipid metabolism. Collectively, these findings demonstrate progressive and coordinated proteomic alterations across multiple biofluids in CLN2 disease that can serve as candidate biomarkers of disease progression.

  • Canine Tear Proteomics: A New Frontier in Veterinary Ophthalmology

    by Albert L. D'AGostino, Elizabeth A. Giuliano, Brandie R. Morgan‐Jack, Grace R. Kick, Juri Ota‐Kuroki, Rebecca E. H. Whiting

    Canine tear proteomics is an emerging field with significant potential for advancing both veterinary ophthalmology and comparative biomedical research. Tears are a readily accessible, non‐invasive biofluid that contain a mixture of proteins involved in ocular surface protection, immune defense, and intercellular signaling. In dogs, tear proteomics studies have revealed biomarkers associated with various ocular and non‐ocular diseases including keratoconjunctivitis sicca (KCS), glaucoma, neoplasia, and diabetes mellitus. This review compiles all previous studies conducted on the comprehensive canine tear proteome and highlights some of the key tear proteomic studies in human biomedical research. Tear film composition, study design, technological advancements, and select tear proteins are discussed along with key protein alterations and their use as potential biomarkers of disease. Fundamental challenges, clinical implications, and future directions of this rapidly growing field are discussed in detail. As proteomic technology and analytical techniques continue to evolve, canine tear proteomics will become a valuable tool for the veterinary ophthalmologist, enabling the early identification and diagnosis of ocular disease as well as providing a means for monitoring treatment outcomes, disease progression, and overall prognosis for the canine patient.

  • Open Access

    Neuronal Ceroid Lipofuscinosis-like Disorder in a Dachshund with Sequence Variants in Lysosome-Related Genes

    by Joan R. Coates, Kristen Keyes, Rebecca E. H. Whiting, Juri Kuroki, Brandie Morgan-Jack, Tendai Mhlanga-Mutangadura, Keiichi Kuroki, Martin L. Katz

    Background/Objectives: Among the most common hereditary neurodegenerative disorders in people are the neuronal ceroid lipofuscinoses (NCLs), a subgroup of lysosomal storage disorders. For most cases of NCL, the genes containing the causative variants have been identified. NCLs also occur in dogs, and in most instances variants responsible for the canine NCLs occur in genes orthologous to those associated with the human disorders. An adult miniature Dachshund presented with clinical signs consistent with NCL. Studies were undertaken to determine whether the disease phenotype supported the classification of the disease as an NCL and to identify potential causal DNA sequence variants. Methods: The proband underwent complete neurological and ophthalmological examinations followed by euthanasia. Tissues were examined for NCL-like pathology. Whole genome sequence analysis (WGS) was performed. Results: The clinical signs and tissue pathology were consistent with those of NCL disease, although with some features distinct from previously described forms of canine NCL. The proband was uniquely homozygous for variants in five genes associated with lysosomal function, four of which have not previously been associated with the NCLs. Conclusions: The proband suffered from a novel NCL-like disorder. Determining whether one or a combination of more than one of the five potentially causal DNA sequence variants was responsible for the disease will require evaluation of additional cases.

  • Open Access

    Neuronal Ceroid Lipofuscinosis-Like Disorder in a Dachshund with Sequence Variants in Lysosome-Related Genes

    by Joan R. Coates, Kristen Keyes, Rebecca E.H. Whiting, Juri Kuroki, Brandie Morgan-Jack, Tendai Mhlanga-Mutangadura, Keiichi Kuroki, Martin L. Katz

    Background/Objectives: Among the most common hereditary neurodegenerative disorders in people are the neuronal ceroid lipofuscinoses (NCLs), a subgroup of lysosomal storage disorders. For most cases of NCL, the genes containing the causative variants have been identified. NCLs also occur in dogs, and in most instances variants responsible for the canine NCLs occur in genes orthologous to those associated with the human disorders. An adult Miniature Dachshund presented with clinical signs consistent with NCL. Studies were undertaken to determine whether the disease phenotype supported classification of the disease as an NCL and to identify potential causal DNA sequence variants. Methods: The proband underwent complete neurologic and ophthalmological examinations followed by euthanasia. Tissues were examined for NCL-like pathology. Whole genome sequence analysis (WGS) was performed. Results: The clinical signs and tissue pathology were consistent with those of NCL disease, although with some features distinct from previously described forms of canine NCL. The proband was uniquely homozygous for variants in 5 genes associated with lysosomal function, 4 of which have not previously been associated with the NCLs. Conclusion: The proband suffered from a novel NCL-like disorder. Determining whether one or a combination of more than one of the 5 potentially causal DNA sequence variants was responsible for the disease will require evaluation of additional cases.

  • Open Access

    Retinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant

    by Grace R. Kick, Samantha L. Marzano, Juri Ota-Kuroki, Garrett Bullock, Martin L. Katz

    American Staffordshire Terriers (ASTs) with a c.296G>A variant in ARSG develop progressive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage material. Human subjects with ARSG variants exhibit hearing loss and rod–cone dystrophy without apparent other neurological involvement and arsg knockout mice exhibit progressive ataxia, lysosomal storage, and photoreceptor loss. Owners of 8 of 11 affected ASTs evaluated for the ARSG risk variant reported observing visual impairment in their dogs, suggesting that the canine disease may involve retinal dysfunction consistent with human subjects and mice with ARSG variants. To assess whether this might be the case, electroretinography was performed on four affected and three unaffected ASTs. Three affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indicative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuated in a younger dog that had not yet shown signs of ataxia or visual impairment. Autofluorescent inclusions were observed in the retinal pigment epithelium and retinal ganglion cell layer of two affected dogs that were euthanized due to neurological disease progression. The results from these cases indicate that standardized electroretinography can be used to detect retinal dysfunction in dogs with the ARSG-related disorder and in other disorders in which dogs exhibit apparent impairment in visually mediated behavior.


  • Open Access

    Retinal Function Deficits in American Staffordshire Terriers with a Late-Onset Neurodegenerative Disease Associated with an ARSG Variant

    by Grace R. Kick, Samantha L. Marzano, Juri Ota-Kuroki, Garrett Bullock, Martin L. Katz

    American Staffordshire Terriers (AST) with a c.296G>A variant in ARSG develop progres-sive ataxia, cerebellar atrophy, and neuronal accumulation of autofluorescent storage ma-terial. Human subjects with ARSG variants exhibit hearing loss and rod-cone dystrophy without apparent neurological involvement and arsg knock-out mice exhibit progressive ataxia, lysosomal storage and photoreceptor loss. A study was undertaken to determine whether ASTs homozygous for the c.296G>A variant exhibit retinal dysfunction con-sistent with human subjects and mice with ARSG variants. Owners of 8 of 11 affected ASTs reported observing late-onset visual impairment in their dogs. Affected dogs that were exhibiting signs of ataxia had attenuated electroretinogram (ERG) amplitudes indic-ative of rod and cone photoreceptor dysfunction, while ERG responses were not attenuat-ed in a younger dog that had not yet shown signs of ataxia or visual impairment. Auto-fluorescent inclusions were observed in the retinal pigment epithelium and retinal gan-glion cell layer of two affected dogs that were euthanized due to neurological disease pro-gression. These results indicate that while the disease phenotype varies between humans, mice and dogs with ARSG variants, progressive photoreceptor dysfunction is a consistent feature in all 3 species.

  • Open Access

    Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis

    by Grace Robinson Kick, Elizabeth J. Meiman, Julianna C. Sabol, Rebecca E.H. Whiting, Juri Ota-Kuroki, Leilani J. Castaner, Cheryl A. Jensen, Martin L. Katz


  • Open Access

    Intravitreal enzyme replacement inhibits progression of retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis

    by Rebecca E.H. Whiting, Grace Robinson Kick, Juri Ota-Kuroki, Stefanie Lim, Leilani J. Castaner, Cheryl A. Jensen, Joseph Kowal, Annalisa Nguyen, Carley Corado, Charles A. O'NEill, et al.


    • 1 September 2017
      • Vol. 58  (9) , 919-922

    Retinal astrocytoma in a dog.

    by Keiichi Kuroki, Nathan Kice, Juri Ota-Kuroki

    A miniature schnauzer dog presenting with hyphema and glaucoma of the right eye had a retinal neoplasm. Neoplastic cells stained positively for glial fibrillary acidic protein, vimentin, and S-100 and largely negatively for oligodendrocyte transcription factor 2 by immunohistochemistry. The clinical and histopathological features of canine retinal astrocytomas are discussed.


  • Open Access

    Limbal xanthogranuloma in a dog

    by Juri Ota-Kuroki, Keiichi Kuroki

    A 10-year-old female spayed American Pitt Bull Terrier was presented with a slow growing mass on the temporal limbus area of the right eye. Canine nodular granulomatous episclerokeratitis was suspected, and the affected eye was treated with 1% prednisolone acetate ophthalmic suspension and 0.03% Tacrolimus ophthalmic solution. As the lesion did not respond to the medical treatments and continued to grow, the mass was excised by lamellar sclerokeratectomy. Microscopically, the mass was composed of granulomatous inflammation with intrahistiocytic lipids and lakes of acicular cholesterol clefts, histopathology findings consistent with xanthogranuloma. To the authors' knowledge, this is the first canine report of limbal xanthogranuloma.